Amgen Inc., 3200 Walnut St., Boulder, CO 80301, USA
Abstract:
A series of 2′–5′ oligoadenylate analogs containing internucleotide and ribose modifications were prepared by solid-phase methods as potential interferon mimetics. All syntheses were carried out using automated methodologies with precursors that allow for the generation of multiple combinations of modification.